Ametek Stock Price, News & Analysis

AMETEK, Inc. (NYSE: AME) will release its first quarter 2021 earnings on May 4, 2021, before market opening.

The company will host a webcast investor conference call at 8:30 AM ET the same day. Interested parties can access the call through the Investors section on www.ametek.com. A replay will be available post-event.

AMETEK generated over $4.5 billion in 2020, aiming for double-digit growth in EPS. The firm is part of the S&P 500.

On March 29, 2021, AMETEK (NYSE: AME) announced the completion of three acquisitions: Magnetrol International, Crank Software, and EGS Automation, with a total expenditure of $270 million. These companies together generate approximately $120 million in annual sales. The acquisitions are expected to enhance AMETEK's capabilities in advanced technology solutions and expand its market presence, particularly in the electronics and automation sectors. This strategic move aligns with AMETEK's growth model focusing on innovation and operational excellence.

AMETEK announced a definitive agreement to acquire Abaco Systems, a provider of embedded computing systems, for $1.35 billion. Abaco Systems specializes in ruggedized computing for aerospace and defense sectors, generating annual sales of approximately $325 million. The acquisition aims to enhance AMETEK's product offerings in attractive markets, with closing anticipated in mid-2021. AMETEK, with sales over $4.5 billion in 2020, targets double-digit earnings growth per share through strategic acquisitions and operational excellence.

AMETEK, Inc. (NYSE: AME) has announced an 11% increase in its quarterly cash dividend to $0.20 per share, up from $0.18. This dividend is payable on March 31, 2021, to shareholders of record as of March 15, 2021, raising the annual rate to $0.80 per share. The company's strong cash flow allows it to invest in growth while rewarding investors. AMETEK reported over $4.5 billion in sales in 2020 and focuses on operational excellence, new product development, and strategic acquisitions to achieve double-digit earnings growth.

AMETEK announced the appointment of Karleen Oberton to its Board of Directors, effective February 11, 2021. Oberton currently serves as CFO of Hologic and has over 30 years of experience in public accounting, biotechnology, and medical device manufacturing. Her expertise in finance and executive leadership is expected to enhance AMETEK's board dynamics. The company reported 2020 sales exceeding $4.5 billion and aims for double-digit growth in earnings per share over the business cycle.

AMETEK reported Q4 2020 sales of $1.20 billion, an 8% decline from Q4 2019. Operating income rose to $298.1 million, yielding a record margin of 24.9%. GAAP earnings per share were $0.95, while adjusted earnings stood at $1.08. Cash flow surged, with operating cash flow up 13% to $386 million and free cash flow up 16% to $349 million. Looking ahead, AMETEK forecasts mid-single-digit sales growth for 2021, with adjusted earnings per diluted share expected between $4.18 and $4.30. Q1 2021 sales are projected to decline low to mid-single digits.

AMETEK, Inc. (NYSE: AME) will release its fourth quarter 2020 earnings on February 4, 2021, before market opens. The investor conference call will follow at 8:30 AM ET, accessible via the 'Events & Presentations' link on www.ametek.com. AMETEK, a leader in electronic instruments and electromechanical devices, reported approximately $5.0 billion in sales for 2019. The company aims for double-digit earnings growth and superior capital returns.

The Board of Directors of AMETEK declared a quarterly dividend of $0.18 per share for Q4, payable on December 24, 2020 to shareholders of record by December 7, 2020. In 2019, AMETEK reported sales of approximately $5.0 billion. The company employs a Growth Model emphasizing Operational Excellence, New Product Development, Global Expansion, and Strategic Acquisitions, aiming for double-digit earnings per share growth and superior capital returns.

AMETEK, Inc. reported Q3 2020 sales of $1.13 billion, a 12% decrease from Q3 2019. Operating income rose to $270.7 million, with operating margins reaching a record 24.0%. GAAP earnings per diluted share were $0.88, while adjusted earnings fell 5% to $1.01, reflecting ongoing challenges from the COVID-19 pandemic. The Electronic Instruments Group saw an 8% drop in sales, while the Electromechanical Group's sales declined by 18%. AMETEK reinstated guidance expecting Q4 sales to be down high single digits year-over-year and adjusted earnings between $1.00 and $1.04.